Communiqués VIA Pharmaceuticals, Inc.

Actions

VIAP

US92554T1034

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 16:48:37 06/05/2026			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-

Communiqués

29/12/09	VIA PHARM : VIA Pharmaceuticals Receives Delisting Notification From NASDAQ	PR
03/12/09	VIA PHARM : VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291	PR
29/10/09	VIA PHARM : VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference	PR
13/10/09	VIA PHARM : VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ	PR
28/09/09	VIA PHARM : VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ	PR
18/09/09	VIA PHARM : VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ	PR
17/07/09	VIA PHARM : VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at Merriman Curhan Ford's Investor Summit 2008	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals Set to Join Russell Microcap Index	PR
30/11/-1	VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals Complies With NASDAQ Rule	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008	PR
30/11/-1	Via Pharmaceutical : VIA Pharmaceuticals to Present at BIO CEO & Investment Conference	PR
30/11/-1	Via Pharmaceuticals : VIA Pharmaceuticals to Present at the ThinkEquity Partners 5th Annual Growth Conference	BU
30/11/-1	Via Pharmaceuticals : VIA Pharmaceuticals to Present at the Noble Financial Conference	BU
30/11/-1	Via Pharmaceuticals : VIA Pharmaceuticals Announces Completion of Its $25 Million Private Placement of Common Stock	BU